Informa Business Intelligence
Informa Pharma Intelligence releases Citeline's next generations of Sitetrove, Trialtrove and new API solutions
The industry's most comprehensive clinical trial data and analysis, now delivered to better fit customers' individual needs and workflows
Summary: Informa Pharma Intelligence announces three major releases for its clinical R&D Intelligence suite. The same leading global intelligence trusted by thousands worldwide for over 35 years is now backed by even more powerful, cutting edge technology. These new solutions will allow users to go deeper with clinical trial research than ever before, and will offer new options to help users better integrate Citeline's leading content with their own data.
LONDON, June 19, 2017 (GLOBE NEWSWIRE) -- Informa Pharma Intelligence, the leading provider of drug, device, company, clinical trial, and market intelligence in the competitive pharma and medtech markets announces today the launch of its next generation of Citeline's Sitetrove and Trialtrove solutions, as well as new application programming interfaces (APIs) for Trials and Drugs. The new solutions are designed to deliver unparalleled access to Citeline's robust clinical trial intelligence with greater ease, speed and efficiency than ever before.
"Our next generation of clinical R&D Intelligence solutions are truly market driven," said Linda Blackerby, President of Informa Pharma Intelligence. "We have partnered with hundreds of customers to understand their data needs and workflows, and have developed our new Citeline platform and APIs based directly on their feedback."
The new Trialtrove and Sitetrove provides users with the ability to go even deeper with search criteria to make better and more well-informed critical decisions, gain competitive advantage, save costs on and optimize ROI for their clinical trials. The new APIs will also come with Informa's acclaimed Ask-the-Analyst service, connecting users with therapeutic expert analysts whose average response time to queries is 24 hours or less.
Informa's new Trials and Drugs APIs will enable users to search or stream information directly from Citeline's R&D Intelligence databases into their own systems and embed Informa's quality datasets directly into their own organization's data and workflows, minimizing duplicated effort and time spent acquiring and manipulating data.
"Clinical R&D professionals need to design strategies, develop protocols, plan and execute trials that are on budget and on time," said Nicola Marlin, Vice President of Product. "Our team of scientific analysts live and breathe the data universe to bring our customers a deep understanding of the current clinical trial landscape. The new Citeline platform and API solutions allow users to enjoy the same depth and breadth of specialized, high caliber content, delivered the way they want to better fit their need, internal solutions, and workflows."
"These new releases further reinforce our commitment to our customers to help them gain critical insights into the global clinical trial landscape, realize greater cost-savings and ROI as they develop on their clinical trial programs," stated Michael Hay, Head of Intelligence. "No other intelligence solution comes close."
Attendees at this week's DIA and BIO International conferences will get a sneak preview of these next generation solutions, which will begin launching to customers in July. Additional solutions including the next generation of Citeline's Pharmaprojects and additional APIs for Investigators and Sites are in development for launch later this year.
For more information, visit pharmaintelligence.informa.com .
About Informa Pharma Intelligence
Informa Pharma Intelligence powers a full suite of analysis products - Datamonitor Healthcare, Sitetrove, Trialtrove, Pharmaprojects, Medtrack, Biomedtracker, Scrip, Pink Sheet and In Vivo - to deliver the data needed by the pharmaceutical and biomedical industry to make decisions and create real-world opportunities for growth.
With more than 500 analysts keeping their fingers on the pulse of the industry, no key disease, clinical trial, drug approval or R&D project isn't covered through the breadth and depth of data available to customers. For more information visit pharmaintelligence.informa.com .
Citeline, part of Informa's Pharma Intelligence vertical, is the world's most comprehensive source of real-time R&D intelligence for the pharmaceutical industry, featuring an unmatched intelligence collection and enrichment of global clinical trials, clinical trial investigator profiles and drug development pipelines.
Citeline is the R&D Intelligence arm of Informa's Pharma Intelligence vertical, one of the world's leading providers of drug, device, company, clinical trial and market intelligence in the pharma and medtech markets. For more information, visit pharmaintelligence.informa.com .
T: (212) 652-5302
Information om Globenewswire
Følg pressemeddelelser fra Globenewswire
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Globenewswire
BlissCo Cannabis Corp.16.11.2018 14:01 | pressemeddelelse
BlissCo Receives Cannabis Sales License from Health Canada
Mitratech16.11.2018 10:01 | pressemeddelelse
Mitratech Listed Among Financial Times’ Inaugural Top 35 Intelligent Business Award Winners and Other Prestigious Categories
Bombardier Inc.16.11.2018 00:07 | pressemeddelelse
Bombardier Will Fully Cooperate with the AMF Review
Erytech Pharma S.A.15.11.2018 22:06 | pressemeddelelse
ERYTECH Partners with New York Blood Center for Red Blood Cell Supply and Research
Motiv Inc.15.11.2018 15:01 | pressemeddelelse
Motiv Ring Expands International Footprint and Delivers Industry-First Sizing Process
Crown Bioscience15.11.2018 14:01 | pressemeddelelse
New Pancreatic Ductal Adenocarcinoma Research Published in Journal of Visualized Experiments
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum